Eisai strikes discovery deal with Genomics; Fast-growing NewLink uses satellite offices to lure new staffers;

@FierceBiotech: Big Pharma partner: Check. Crossover round: Check. Hot tech: Check. IPO? Report | Follow @FierceBiotech

@JohnCFierce: Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact. News | Follow @JohnCFierce

> Eisai and the U.K.'s Genomics plc have forged a collaboration that will rely on Genomics' "statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai's drug discovery process, including target selection, target validation, indication selection and repositioning." Release

> A fast-growing NewLink Genetics has been adding satellite offices in Austin and Boston as the biotech tests the limits of recruiting scientists and relocating them to Iowa, reports the Wall Street Journal. Report

> Cambridge, MA-based Hydra Biosciences has struck a deal to work with Boehringer Ingelheim to ID small-molecule TRP inhibitors with a special focus on renal diseases. This pact follows a deal last year to collaborate on small-molecule TRPC4/5 inhibitors for CNS ailments. Release

Medical Device News

@FierceMedDev: FDA announces LuSys Labs' recall of its unapproved Ebola diagnostic. FierceDiagnostics article | Follow @FierceMedDev

@EmilyWFierce: NIH awards $11M to develop tests for drug-resistant bacteria. More from FierceDiagnostics | Follow @EmilyWFierce

> Qualcomm extends its Life2Net reach in deal with Cerner. Story

> ReCor Medical reels in $15M to recharge renal denervation efforts. Article

Pharma News

@FiercePharma: North Carolina shuts down animal drug compounder. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: Here's Baxter release on recall of 8 saline lots, 4 dextrose, 3 Lactated Ringer's Injection. Release | Follow @EricPFierce

> Zoloft lawyers accuse Pfizer of hiding birth-defect risks. Article

> Sanofi won't discount Toujeo to Lantus. Story

Animal Health News

> Zoetis innovation lab seeks to create electronic health record for every U.K. farm animal. Report

> Jennie-O-Turkey plant struck by bird flu. Story

> Mylan seeks entry into animal health via $29B bid for Perrigo. Item

> North Carolina shuts down animal drug compounder. Article

> Chicago outbreak of dog flu has authorities pitching Merck vaccine. More

Biotech IT News

> Rise of Big Data prompts peer review rethink at Nature Biotechnology. Item

> Early user of Venter's DNA synthesizer reports saving time, money. Report

> BioXcel adds Takeda to its roster of A-list clients. More

> Eisai's new research unit taps Genomics for analysis support. Story

> Peking University inks Medidata deal as China inches into eClinical era. Article

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.